Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Appili Therapeutics Inc.
DescriptionTaste-masked reformulation of metronidazole
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationClostridium
Indication DetailsTreat Clostridium difficile infection (CDI) in children
Regulatory Designation U.S. - Orphan Drug (Treat Clostridium difficile infection (CDI) in children)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today